| Year |
Citation |
Score |
| 2022 |
Lilly JV, Rokita JL, Mason JL, Patton T, Stefankiewiz S, Higgins D, Trooskin G, Larouci CA, Arya K, Appert E, Heath AP, Zhu Y, Brown MA, Zhang B, Farrow BK, ... ... Choudhari N, et al. The children's brain tumor network (CBTN) - Accelerating research in pediatric central nervous system tumors through collaboration and open science. Neoplasia (New York, N.Y.). 35: 100846. PMID 36335802 DOI: 10.1016/j.neo.2022.100846 |
0.476 |
|
| 2021 |
Tong CCL, Koptyra M, Raman P, Rathi KS, Choudhari N, Lin X, Seckar T, Wei Z, Kohanski MA, O'Malley BW, Cohen NA, Kennedy DW, Adappa ND, Robertson ES, Baranov E, et al. Targeted gene expression profiling of inverted papilloma and squamous cell carcinoma. International Forum of Allergy & Rhinology. PMID 34510780 DOI: 10.1002/alr.22882 |
0.467 |
|
| 2019 |
Ijaz H, Baubet V, Koptyra M, Raman P, Tauhid L, Gaonkar K, Zhu Y, Zhang B, Choudhari N, Galanaugh J, Appert E, Mason J, Cripe L, Lis T, Santi MR, et al. TMOD-18. AN INTEGRATED SET OF PEDIATRIC HIGH GRADE GLIOMA RESOURCES FOR TRANSLATIONAL STUDIES Neuro-Oncology. 21: ii124-ii125. DOI: 10.1093/Neuonc/Noz036.255 |
0.49 |
|
| 2018 |
Foster JB, Choudhari N, Perezzelli J, Storm J, Hofmann TJ, Jain P, Storm PB, Pardi N, Weissman D, Waanders AJ, Grupp SA, Kariko K, Resnick AC, Barrett DM. Purification of mRNA encoding chimeric antigen receptor is critical for generation of robust T cell response. Human Gene Therapy. PMID 30024272 DOI: 10.1089/Hum.2018.145 |
0.539 |
|
| 2018 |
Koptyra MP, Choudhari N, Zhe Z, Santi M, Waanders A, Resnick A. Abstract 2081: Empowering rare disease cohort biomarker discovery via comparative assessments of gene expression analysis platforms for FFPE pediatric brain tumor specimens Tumor Biology. DOI: 10.1158/1538-7445.Am2018-2081 |
0.53 |
|
| 2018 |
Koptyra M, Baubet V, Tauhid L, Choudhari N, Smith T, Cole K, Ijaz H, Waanders A, Resnick A. HGG-40. HIGH GRADE GLIOMA CELL LINE COHORT AS AN EXAMPLE OF CHILDREN’S BRAIN TUMOR TISSUE CONSORTIUM TUMOR SPECIMEN PROCESSING PIPELINE Neuro-Oncology. 20: i97-i97. DOI: 10.1093/Neuonc/Noy059.312 |
0.534 |
|
| 2017 |
Jain P, Silva A, Han HJ, Lang SS, Zhu Y, Boucher K, Smith TE, Vakil A, Diviney P, Choudhari N, Raman P, Busch CM, Delaney T, Yang X, Olow AK, et al. Overcoming resistance to single-agent therapy for oncogenic BRAF gene fusions via combinatorial targeting of MAPK and PI3K/mTOR signaling pathways. Oncotarget. 8: 84697-84713. PMID 29156677 DOI: 10.18632/Oncotarget.20949 |
0.558 |
|
| 2017 |
Foster J, Choudhari N, Resnick A, Barrett D. Abstract 5614: Novel mRNA purification method with RNaseIII improves efficacy of RNA chimeric antigen receptor T cells Cancer Research. 77: 5614-5614. DOI: 10.1158/1538-7445.Am2017-5614 |
0.535 |
|
| 2016 |
Bandopadhayay P, Ramkissoon LA, Jain P, Bergthold G, Wala J, Zeid R, Schumacher SE, Urbanski L, O'Rourke R, Gibson WJ, Pelton K, Ramkissoon SH, Han HJ, Zhu Y, Choudhari N, et al. MYB-QKI rearrangements in angiocentric glioma drive tumorigenicity through a tripartite mechanism. Nature Genetics. PMID 26829751 DOI: 10.1038/Ng.3500 |
0.553 |
|
| 2016 |
Foster J, Choudhari N, Barrett D, Resnick A. Abstract B083: Novel mRNA manufacturing techniques using modification of nucleosides and purification improves the efficacy of mRNA chimeric antigen receptor T cells Cancer Immunology Research. 4. DOI: 10.1158/2326-6066.Imm2016-B083 |
0.532 |
|
| 2016 |
Vakil A, Silva A, Han HJ, Choudhari N, Storm PB, Resnick AC, Davare MA, Waanders AJ. LG-64COMBINATORIAL TARGETING OF ONCOGENIC FGFR1 GENE REARRANGEMENTS IN PEDIATRIC GLIOMAS Neuro-Oncology. 18: iii93.2-iii93. DOI: 10.1093/Neuonc/Now075.64 |
0.527 |
|
| 2015 |
Waanders A, Silva A, Chen S, Han H, Zhu Y, Boucher K, Jain P, Fierst T, Choudhari N, Mueller S, Haas-Kogan D, Storm P, Resnick A. TR-06 * COMBINATORIAL PATHWAY TARGETING APPROACHES FOR BRAF-FUSIONS ASSOCIATED WITH PEDIATRIC LOW-GRADE GLIOMAS Neuro-Oncology. 17: iii37-iii38. DOI: 10.1093/Neuonc/Nov061.151 |
0.571 |
|
| 2013 |
Sievert AJ, Lang SS, Boucher KL, Madsen PJ, Slaunwhite E, Choudhari N, Kellet M, Storm PB, Resnick AC. Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomas. Proceedings of the National Academy of Sciences of the United States of America. 110: 5957-62. PMID 23533272 DOI: 10.1073/Pnas.1219232110 |
0.578 |
|
| 2011 |
Maag D, Maxwell MJ, Hardesty DA, Boucher KL, Choudhari N, Hanno AG, Ma JF, Snowman AS, Pietropaoli JW, Xu R, Storm PB, Saiardi A, Snyder SH, Resnick AC. Inositol polyphosphate multikinase is a physiologic PI3-kinase that activates Akt/PKB. Proceedings of the National Academy of Sciences of the United States of America. 108: 1391-6. PMID 21220345 DOI: 10.1073/Pnas.1017831108 |
0.498 |
|
| 2011 |
Sievert AJ, Lang S, Choudhari N, Katie B, Sonam S, Biegel JA, Storm PB, Resnick AC. Abstract 3457: The KIAA1549-BRAF fusion oncogene in pediatric low-grade gliomas undergoes in vitro paradoxical activation in response to RAF specific inhibition Cancer Research. 71: 3457-3457. DOI: 10.1158/1538-7445.Am2011-3457 |
0.611 |
|
| Show low-probability matches. |